<DOC>
	<DOC>NCT02359474</DOC>
	<brief_summary>This trial compares trabectedin alone to trabectedin in combination with regional hyperthermia in patients with high-risk soft tissue sarcoma. The study is designed to demonstrate a significant benefit for sarcoma-therapy by adding regional hyperthermia.</brief_summary>
	<brief_title>Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Trabectedin</mesh_term>
	<criteria>Age &gt; 18 years Histologically confirmed STS (primary or recurrent), except: Ewing sarcoma, osteosarcoma, skeletal chondrosarcoma (extraskeletal chondrosacomas are included), GIST, dermatofibrosarcoma protuberans, malignant mesothelioma, rhabdomyosarcoma Patients after failure of firstline chemotherapy (anthracyclines and ifosfamide) with or without RHT Progressive or recurrent tumor which is unresectable or only resectable with adverse functional outcome After macroscopic incomplete resection or marginal resection (tumorfree margins &lt; 1 cm) Prior chemotherapy, including anthracyclines and ifosfamide (with or without RHT) or patients who cannot be given these medicines Oligometastasis (â‰¤ 5 lesions) Performance status (ECOG) 0,1 or 2 More than 3 weeks from last treatment Neutrophil count &gt; 1,5 G/l, hemoglobin &gt; 9 g/dl, platelets &gt; 100 G/l Albumin &gt; 25 g/l, total bilirubin &lt; 1 x ULN, ALT/AST &lt; 2.5 x ULN, AP &lt; 2.5 x ULN, Cockroft and Gault's calculated creatinine clearance &gt; 30 ml/min, CPK &lt; 2.5 x ULN Patients with the ability to follow study instructions and likely to attend and complete all required visits Written informed consent of the subject Uncontrolled infection (e.g. active viral hepatitis) Unstable cardiac status Peripheral neuropathy &gt; grade 2 Known or persistent abuse of medications, drugs or alcohol Other malignancy during the last 5 years (exclusion of basal cell carcinoma or adequately treated cervical carcinoma in situ) Prior therapy with Tr or known history of hypersensitivity to drugs with a similar chemical structure Pregnancy or breastfeeding Females of childbearing potential, who are not using and not willing to use medically reliable methods of contraception for the entire study duration Uncontrolled CNSmetastases Medical or technical impossibility for hyperthermia to heat the major target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>high-risk soft tissue sarcoma</keyword>
	<keyword>trabectedin</keyword>
</DOC>